Could cannabis-derived medicine help type 2 diabetes sufferers?
In an article published in today’s issue of the Society of Biology’s magazine, The Biologist, GW Pharmaceuticals’ Director of Botanical Research and Cultivation, Dr David Potter, discusses how cannabis could be bred to provide raw starting material for a medicine to treat metabolic disorders.
Researchers at the UK’s only legal cannabis production facility are researching ways to use highly-standardised extracts from the plant to tackle metabolic syndrome, and are studying how such products could potentially treat conditions as diverse as cancer pain, epilepsy, ulcerative colitis, psychosis and brain injury. GW Pharmaceuticals’ first licensed medicine, Sativex, is already used to treat muscle spasticity in MS patients and primarily contains two principal cannabinoids: THC and CBD. But the medical potential of the remaining, minor cannabinoids is also huge.
Dr Potter says: “Metabolic syndrome is a disruption of the way the body metabolises food to produce energy or to store as fat. It is most common in obese people and can lead to major health problems such as Type II diabetes.”
Obesity, with all its effects on human health, is widespread. The GW Pharmaceuticals team is exploring how they can use cannabis-derived medicines to tackle one aspect of the problem. Phase IIa clinical studies are evaluating specific cannabinoids as potential treatments for metabolic syndrome and Type II diabetes. This builds upon pre-clinical data demonstrating the desirable effects of a number of cannabinoids on insulin resistance, cholesterol and liver fat, all features of metabolic disease.
Dr Potter’s team has successfully bred cannabis plants which produce high levels of a cannabinoid called THCV (delta-9-tetrahydrocannabivarin). THCV is normally only present in minor quantities; its structure is similar to THC but it exhibits very different pharmacology. It has shown promise as a potential treatment for Type II diabetes by virtue of controlling and modulating a range of factors involved in lipid deposition, cellular energy expenditure and insulin resistance - the key pathophysiological features of metabolic syndrome.
Dr Mark Downs, Chief Executive of the Society of Biology, says:
“Metabolic syndrome, and the health problems it leads to, is a huge strain on the NHS, and can massively reduce the quality of life of those affected. It is always exciting to see new avenues being explored to tackle the issue.”
There are many potential therapies for metabolic syndrome and the other conditions highlighted, and the therapeutic use of compounds found in the cannabis plant is one of the various promising routes for new treatments.
GW’s licensed medicine, Sativex, primarily contains the two most common cannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). It is currently prescribed to MS sufferers and is currently undergoing Phase III trials for the treatment of pain in the advanced stages of cancer.
Although THC and CBD are the most well-known cannabinoids and appear at the highest concentrations, there are nearly 60 less common cannabinoids (such as THCV) and GW has studied approximately 20 of these.
One of the technical challenges of studying these minor cannabinoids is to breed cannabis plants with high concentrations of the cannabinoid of interest.
Dr Potter says: “My team’s task is to run a selective breeding programme for minor cannabinoids which have been identified as having clinical potential. Thankfully cannabis has a fast growing cycle, with several crops per year. This means we can often produce suitable plants within a few years or even less.”
Epilepsy and brain injury
Compounds developed by GW have shown promise in the treatment of epilepsy, and the company has recently discovered that cannabinoids are able to reduce the expression of certain epilepsy-related genes. This opens up an exciting possibility of using cannabinoids as personalised epilepsy medicines; patients most likely to respond can be identified by the presence of a specific gene.
Dr Potter points out that modern ‘skunk’ cannabis has been bred by recreational users to increase the concentration of THC while decreasing the concentration of CBD. Whereas THC has been linked to psychosis, CBD has anti-psychotic properties, so may provide some protection from the effects of THC. The lack of CBD in skunk potentially makes this form of cannabis more likely to induce harmful psychoses, especially in young teenagers whose brains are not yet fully developed.
GW Pharmaceuticals is also testing the use of medicines based on CBD for the treatment of psychiatric disorders. Encouraging in vivo studies suggest that, because of its anti-inflammatory properties, CBD could also be useful in treating brain injury, both in accident victims and newborns starved of oxygen at birth.
Dr Potter says: “As rigorous modern research with cannabinoids comes to fruition, a new era of treatment options may have arrived.”
Provided by Society of Biology
- New research provides hope for those with epilepsy Apr 11, 2011 | not rated yet | 0
- Study confirms that cannabis is beneficial for multiple sclerosis Dec 04, 2009 | not rated yet | 0
- Weeding out the highs of medical marijuana Jul 15, 2008 | not rated yet | 0
- Endogenous cannabinoids linked to fetal brain damage imposed by maternal cannabis use May 24, 2007 | not rated yet | 0
- Cannabis compound can help cells Feb 19, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How can there be a term called "intestinal metaplasia" of stomach
6 hours ago Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
- More from Physics Forums - Medical Sciences
More news stories
Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...
Medical research 35 minutes ago | not rated yet | 0 |
Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...
Medical research 1 hour ago | not rated yet | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Medical research 1 hour ago | 4.5 / 5 (2) | 0 |
Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play ...
Medical research 4 hours ago | not rated yet | 0
Nearly 20 percent of kidneys that are recovered from deceased donors in the U.S. are refused for transplant due to factors ranging from scarring in small blood vessels of the kidney's filtering units to the organ going too ...
Medical research 20 hours ago | 5 / 5 (2) | 0 |
The level of immunity to the recently circulating H7N9 influenza virus in an urban and rural population in Vietnam is very low, according to the first population level study to examine human immunity to the virus, which was ...
1 hour ago | not rated yet | 0 |
You're standing near an airport luggage carousel and your bag emerges on the conveyor belt, prompting you to spring into action. How does your brain make the shift from passively waiting to taking action when ...
11 minutes ago | not rated yet | 0 |
Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with blurred vision, ...
1 hour ago | not rated yet | 0
Youth who had a schoolmate die by suicide are significantly more likely to consider or attempt suicide, according to a study in published in CMAJ (Canadian Medical Association Journal). This effect can last 2 years or mo ...
46 minutes ago | not rated yet | 0
Most elite athletes consider doping substances "are effective" in improving performance, while recognising that they constitute cheating, can endanger health and entail the obvious risk of sanction. At the same time, the ...
45 minutes ago | not rated yet | 0
Knee replacement surgery is a very common procedure. However, it does not always resolve function or pain in all the recipients of new knees. A study by Robert Barrack, MD and his colleagues from the Washington University ...
1 hour ago | not rated yet | 0